0001637931-17-000002.txt : 20171205 0001637931-17-000002.hdr.sgml : 20171205 20171204191954 ACCESSION NUMBER: 0001637931-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171205 DATE AS OF CHANGE: 20171204 EFFECTIVENESS DATE: 20171205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semma Therapeutics, Inc. CENTRAL INDEX KEY: 0001637931 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300037 FILM NUMBER: 171238364 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: STE 2B CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-901-4221 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: STE 2B CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001637931 Semma Therapeutics, Inc. 450 KENDALL STREET STE 2B CAMBRIDGE MA MASSACHUSETTS 02142 857-529-6430 DELAWARE None None Corporation true 2014 Elizabeth Stoner 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Todd Foley 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Stephen Knight 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Mitchell Finer 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Kingsley Taft 100 Northern Ave Boston MA MASSACHUSETTS 02210 Executive Officer Mark Fishman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director William Sahlman 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Kevin Raidy 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Daniel Auerbach 450 Kendall Street STE 2B Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2017-11-27 true true false 0 113860712 53860712 60000000 Series B Preferred Stock. Total amount sold includes $13,860,712 from note conversions. false 20 0 0 0 false Semma Therapeutics, Inc. /s/Elizabeth Stoner Elizabeth Stoner Chief Executive Officer 2017-12-04